TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 35108378

Group type: EXPERIMENTAL
Intervention: High Carbohydrate, High Starch (HC-Starch) diet (57% carbohydrate and 25% fat, including 20% refined grains)
Number of subjects: 64

Group type: EXPERIMENTAL
Intervention: High Carbohydrate, High Sugar (HC-Sugar) diet (57% carbohydrate and 25% fat, including 20% sugar)
Number of subjects: 64

Group type: COMPARATOR
Intervention: Very-Low-Carbohydrate (VLC) diet (5% carbohydrate and 77% fat)
Number of subjects: 64

Group type: EXPERIMENTAL
Intervention: High Carbohydrate, High Starch (HC-Starch) and High Carbohydrate, High Sugar (HC-Sugar) diets
Number of subjects: 64
Study: 32414335

Group type: EXPERIMENTAL
Intervention: ICD‐10 codes for social anxiety disorder (SAD)
Number of subjects: 95

Group type: EXPERIMENTAL
Intervention: Inter-rater agreement regarding the presence or absence of SAD
Number of subjects: 95

Group type: EXPERIMENTAL
Intervention: CGI‐S and GAF scores
Number of subjects: 95

Group type: EXPERIMENTAL
Intervention: Inter-rater agreement for CGI‐S and GAF
Number of subjects: 95
Study: 36478278

Group type: EXPERIMENTAL
Intervention: Ultrasound-guided percutaneous A1 pulley release
Number of subjects: 84

Group type: COMPARATOR
Intervention: Classic open surgery
Number of subjects: 84
Study: 35595196

Group type: EXPERIMENTAL
Intervention: 3D-printed splint (3DPS)
Number of subjects: 34

Group type: COMPARATOR
Intervention: Conventional removable splint (CRS)
Number of subjects: 34
Study: 33729386

Group type: EXPERIMENTAL
Intervention: Intravenous thrombolysis with alteplase
Number of subjects: 120

Group type: COMPARATOR
Intervention: Intravenous thrombolysis with batroxobin
Number of subjects: 120
Study: 32854478

Group type: COMPARATOR
Intervention: Control group (normal pregnant women)
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Preeclampsia group
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: LPS group
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: sh‐KCNQ1OT1 group
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: miR‐146a‐3p inhibitor group
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: sh‐KCNQ1OT1+miR‐146a‐3p inhibitor group
Number of subjects: 100
Study: 32208848

Group type: EXPERIMENTAL
Intervention: Grape juice (200-500 mL/day)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Light-to-moderate wine (1-4 glasses/day)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Other alcoholic beverages
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Resveratrol (150-1000 mg/day)
Number of subjects: 0
Study: 34609549

Group type: EXPERIMENTAL
Intervention: Tocilizumab plus remdesivir
Number of subjects: 649

Group type: COMPARATOR
Intervention: Placebo plus remdesivir
Number of subjects: 649
Study: 34279759

Group type: EXPERIMENTAL
Intervention: Group Cognitive-Behavioral Intervention (Healthy Minds) consisting of eight sessions based on cognitive behavioral therapy principles and techniques.
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Group Cognitive-Behavioral Intervention (Healthy Minds)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Usual services (Control group)
Number of subjects: 30
Study: 33599062

Group type: EXPERIMENTAL
Intervention: Platelet-rich plasma (PRP) injections every month for a maximum of two sessions
Number of subjects: 25
Study: 33027488

Group type: EXPERIMENTAL
Intervention: Educational intervention with serial album
Number of subjects: 90

Group type: COMPARATOR
Intervention: Control group (CG)
Number of subjects: 90
Study: 33393736

Group type: EXPERIMENTAL
Intervention: Dark adaptation protocol followed by intense retinal photobleaching
Number of subjects: 20

Group type: COMPARATOR
Intervention: Constant ambient light without any variation (Control)
Number of subjects: 20
Study: 33940637

Group type: EXPERIMENTAL
Intervention: Fast needle acceleration (higher than 1 g)
Number of subjects: 51

Group type: COMPARATOR
Intervention: Slow needle acceleration (lower than 1 g)
Number of subjects: 51
Study: 33448941

Group type: EXPERIMENTAL
Intervention: Air-Fluidized Therapy (AFT)
Number of subjects: 4

Group type: EXPERIMENTAL
Intervention: Fluid Immersion System (FIS)
Number of subjects: 4
Study: 35113957

Group type: EXPERIMENTAL
Intervention: Combined training (aerobic plus resistance training) for 16 weeks
Number of subjects: 40

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 40
Study: 33280393

Group type: EXPERIMENTAL
Intervention: Prompt surgery (<48 hours)
Number of subjects: 921

Group type: COMPARATOR
Intervention: Delayed surgery (>48 hours)
Number of subjects: 921
Study: 32476054

Group type: EXPERIMENTAL
Intervention: Submaximal exercise (inclined walking)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Submaximal exercise
Number of subjects: 20

Group type: COMPARATOR
Intervention: Hypercapnia (CO2-control)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Increased PETCO2 (3-6%)
Number of subjects: 20
Study: 35710539

Group type: EXPERIMENTAL
Intervention: Antihypertensive medication reduction
Number of subjects: 0

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 0
Study: 33319495

Group type: EXPERIMENTAL
Intervention: SP (S-1 and cisplatin)
Number of subjects: 110

Group type: COMPARATOR
Intervention: DP (docetaxel and cisplatin)
Number of subjects: 110
Study: 34101780

Group type: EXPERIMENTAL
Intervention: Folic acid 1.2 mg/d + vitamin B12 50 μg/d
Number of subjects: 120

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 120
Study: 32858346

Group type: EXPERIMENTAL
Intervention: Trazodone 50 mg/d (TRAZ)
Number of subjects: 75

Group type: EXPERIMENTAL
Intervention: Sleep hygiene training (SHT)
Number of subjects: 75

Group type: EXPERIMENTAL
Intervention: Sleep hygiene training and trazodone (SHT + TRAZ)
Number of subjects: 75

Group type: COMPARATOR
Intervention: Control (no intervention)
Number of subjects: 75

Group type: EXPERIMENTAL
Intervention: All conditions
Number of subjects: 75
Study: 36216827

Group type: EXPERIMENTAL
Intervention: Sunitinib treatment
Number of subjects: 171

Group type: EXPERIMENTAL
Intervention: Anti-angiogenic adjuvant therapy
Number of subjects: 171
Study: 33794303

Group type: EXPERIMENTAL
Intervention: End-of-life care staff training intervention (four 4-hour educational workshops on palliative care principles)
Number of subjects: 324

Group type: COMPARATOR
Intervention: Control group (no specific intervention mentioned)
Number of subjects: 324

Group type: EXPERIMENTAL
Intervention: End-of-life care staff training intervention
Number of subjects: 324
Study: 32011015

Group type: EXPERIMENTAL
Intervention: Guided Bone Regeneration (GBR)
Number of subjects: 22

Group type: COMPARATOR
Intervention: Spontaneous Healing (SH)
Number of subjects: 22
Study: 35297582

Group type: COMPARATOR
Intervention: Conventional group (group A: 120 kV, 100 mA)
Number of subjects: 250

Group type: EXPERIMENTAL
Intervention: Low-dose group B (100 kV, 100 mA)
Number of subjects: 250

Group type: EXPERIMENTAL
Intervention: Low-dose group C (100 kV, 50 mA)
Number of subjects: 250

Group type: EXPERIMENTAL
Intervention: Low-dose group D (80 kV, 100 mA)
Number of subjects: 250

Group type: EXPERIMENTAL
Intervention: Low-dose group E (80 kV, 50 mA)
Number of subjects: 250
Study: 32164877

Group type: EXPERIMENTAL
Intervention: 131I-metuximab (27.75 MBq/kg) administered as a single transarterial injection 4-6 weeks after hepatectomy
Number of subjects: 156

Group type: COMPARATOR
Intervention: No adjuvant treatment (control group)
Number of subjects: 156

Group type: EXPERIMENTAL
Intervention: 131I-metuximab
Number of subjects: 156
Study: 36130751

Group type: EXPERIMENTAL
Intervention: iSupport intervention
Number of subjects: 350

Group type: COMPARATOR
Intervention: Standardised information about caring for someone with dementia (control)
Number of subjects: 350
Study: 32173259

Group type: EXPERIMENTAL
Intervention: Accumulated walking exercise (APPW) - three 10-min walking bouts after breakfast, lunch, and dinner
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Single bout walking exercise (CPPW) - single 30-min walking bout after dinner
Number of subjects: 10

Group type: COMPARATOR
Intervention: No-exercise control (NOEX)
Number of subjects: 10
Study: 35048745

Group type: EXPERIMENTAL
Intervention: Dasotraline 2 mg/day
Number of subjects: 95

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 95
Study: 33236355

Group type: EXPERIMENTAL
Intervention: SINC feeding protocol
Number of subjects: 80

Group type: COMPARATOR
Intervention: Standard feeding (Control)
Number of subjects: 80
Study: 33547266

Group type: EXPERIMENTAL
Intervention: ET + RT40
Number of subjects: 16

Group type: COMPARATOR
Intervention: ET + RT20
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: RT40 + ET
Number of subjects: 16

Group type: COMPARATOR
Intervention: RT20 + ET
Number of subjects: 16
Study: 32881138

Group type: EXPERIMENTAL
Intervention: 600 mg/kg ALA
Number of subjects: 180

Group type: EXPERIMENTAL
Intervention: ALA-treated groups
Number of subjects: 180
Study: 35808221

Group type: EXPERIMENTAL
Intervention: Push Band 2.0 (PB2.0)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: OptoJump (OPT)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Force Plate (FP)
Number of subjects: 20
Study: 33674241

Group type: EXPERIMENTAL
Intervention: Add-on self-care therapy education
Number of subjects: 267
Study: 35979259

Group type: EXPERIMENTAL
Intervention: Saccharomyces cerevisiae I-3856 (8 × 10^9 CFU daily)
Number of subjects: 456

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 456

Group type: EXPERIMENTAL
Intervention: Saccharomyces cerevisiae I-3856
Number of subjects: 456
Study: 32875658

Group type: EXPERIMENTAL
Intervention: Rotigotine 3 mg per day for 6 weeks
Number of subjects: 70

Group type: COMPARATOR
Intervention: Placebo for 6 weeks
Number of subjects: 70
Study: 35999352

Group type: EXPERIMENTAL
Intervention: Heparin
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Monoclonal antibody crizanlizumab
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Sodium-glucose cotransporter-2 inhibitors
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Purinergic signaling receptor Y12 inhibitors
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 34795191

Group type: EXPERIMENTAL
Intervention: Dance therapy based on the Satir Model and group psychological intervention
Number of subjects: 62

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 62
Study: 32756081

Group type: EXPERIMENTAL
Intervention: Combined multiprofessional education program
Number of subjects: 12

Group type: COMPARATOR
Intervention: Control period (no intervention)
Number of subjects: 12
Study: 35144974

Group type: EXPERIMENTAL
Intervention: Famotidine 80 mg orally three times a day for 14 days
Number of subjects: 55

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 55

Group type: EXPERIMENTAL
Intervention: Famotidine
Number of subjects: 55

Group type: COMPARATOR
Intervention: Famotidine and Placebo
Number of subjects: 55
Study: 34116637

Group type: EXPERIMENTAL
Intervention: 2-octyl cyanoacrylate glue (Dermabond®)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Sterile strips
Number of subjects: 30
Study: 32379766

Group type: EXPERIMENTAL
Intervention: Hidden conditioning
Number of subjects: 87

Group type: EXPERIMENTAL
Intervention: Open conditioning
Number of subjects: 87

Group type: COMPARATOR
Intervention: Control
Number of subjects: 87
Study: 36273430

Group type: EXPERIMENTAL
Intervention: Multifamily therapy (MFT) - 24 sessions in addition to treatment as usual (TAU)
Number of subjects: 55

Group type: COMPARATOR
Intervention: Treatment as usual (TAU) - individual and family sessions
Number of subjects: 55
Study: 33380182

Group type: EXPERIMENTAL
Intervention: Robotic TKA
Number of subjects: 30

Group type: COMPARATOR
Intervention: Conventional TKA
Number of subjects: 30
Study: 32383337

Group type: EXPERIMENTAL
Intervention: Pregnancy-related deaths
Number of subjects: 536233

Group type: EXPERIMENTAL
Intervention: Timing of maternal deaths
Number of subjects: 536233

Group type: EXPERIMENTAL
Intervention: Age distribution of maternal deaths
Number of subjects: 536233

Group type: COMPARATOR
Intervention: Association with obstetric resources
Number of subjects: 536233
Study: 36417403

Group type: EXPERIMENTAL
Intervention: Cognitive-behavioral therapy (CBT)
Number of subjects: 29
Study: 32743951

Group type: EXPERIMENTAL
Intervention: Cardiometabolic monitoring practices
Number of subjects: 228

Group type: EXPERIMENTAL
Intervention: Blood pressure measurement
Number of subjects: 228

Group type: EXPERIMENTAL
Intervention: Waist circumference measurement
Number of subjects: 228

Group type: EXPERIMENTAL
Intervention: Compliance with recommended cardiometabolic monitoring
Number of subjects: 228

Group type: EXPERIMENTAL
Intervention: Statistical associations
Number of subjects: 228
Study: 36305925

Group type: EXPERIMENTAL
Intervention: Botulinum toxin type A (BT) injected into the smile muscle locations 15 days before surgery
Number of subjects: 18

Group type: COMPARATOR
Intervention: Lip repositioning surgery only (Control group)
Number of subjects: 18
Study: 33481822

Group type: EXPERIMENTAL
Intervention: Good Enough Parenting program
Number of subjects: 55
Study: 32333714

Group type: EXPERIMENTAL
Intervention: Rectal hydrogel spacer
Number of subjects: 380

Group type: COMPARATOR
Intervention: Control (no rectal hydrogel spacer)
Number of subjects: 380
Study: 34366208

Group type: EXPERIMENTAL
Intervention: Oropharyngeal packing
Number of subjects: 30

Group type: COMPARATOR
Intervention: No packing
Number of subjects: 30
Study: 33853701

Group type: EXPERIMENTAL
Intervention: Cognitive Remediation for Schizophrenia (RECOS)
Number of subjects: 79

Group type: COMPARATOR
Intervention: Treatment As Usual (TAU)
Number of subjects: 79
Study: 35122485

Group type: EXPERIMENTAL
Intervention: Extracorporeal shock wave therapy (ESWT)
Number of subjects: 22

Group type: COMPARATOR
Intervention: Sham-extracorporeal shock wave therapy (sham-ESWT)
Number of subjects: 22
Study: 34775718

Group type: EXPERIMENTAL
Intervention: Remote 'Internet+' interaction mode
Number of subjects: 394

Group type: COMPARATOR
Intervention: Traditional blood pressure control mode
Number of subjects: 394
Study: 32807727

Group type: EXPERIMENTAL
Intervention: Testosterone suppression with docetaxel
Number of subjects: 0

Group type: COMPARATOR
Intervention: Testosterone suppression without docetaxel
Number of subjects: 0
Study: 35765022

Group type: EXPERIMENTAL
Intervention: Irrigation with 37 °C constant temperature saline
Number of subjects: 110

Group type: COMPARATOR
Intervention: Room temperature irrigation (Control)
Number of subjects: 110
Study: 32214297

Group type: EXPERIMENTAL
Intervention: Dexmedetomidine combined with ketorolac (DEX group)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Sufentanil combined with ketorolac (SUF group)
Number of subjects: 60
Study: 35770540

Group type: EXPERIMENTAL
Intervention: Auricular ASP needles treatment
Number of subjects: 80

Group type: COMPARATOR
Intervention: Routine treatments (Control)
Number of subjects: 80
Study: 32952015

Group type: EXPERIMENTAL
Intervention: Rumen-protected methionine (RPM)
Number of subjects: 74

Group type: EXPERIMENTAL
Intervention: HMTBa
Number of subjects: 74

Group type: EXPERIMENTAL
Intervention: HMBi
Number of subjects: 74

Group type: COMPARATOR
Intervention: Control (CTRL)
Number of subjects: 74
Study: 35242730

Group type: EXPERIMENTAL
Intervention: Azithromycin treatment (four biannual rounds)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Azithromycin treatment (two biannual rounds)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control (baseline)
Number of subjects: 0
Study: 35682140

Group type: EXPERIMENTAL
Intervention: Contrast Strength Training (CST)
Number of subjects: 31

Group type: COMPARATOR
Intervention: Control Group
Number of subjects: 31
Study: 33950544

Group type: EXPERIMENTAL
Intervention: Tea Tree Oil (10% solution, 5 mL)
Number of subjects: 112

Group type: EXPERIMENTAL
Intervention: Alcohol (83% ethanol, 2 mL)
Number of subjects: 112

Group type: EXPERIMENTAL
Intervention: Benzalkonium Chloride (0.8 mL)
Number of subjects: 112

Group type: COMPARATOR
Intervention: Control (no treatment)
Number of subjects: 112
Study: 32475274

Group type: EXPERIMENTAL
Intervention: Essential amino acid supplementation (9 g daily)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Placebo (lactose powder, 9 g daily)
Number of subjects: 60
Study: 34597713

Group type: EXPERIMENTAL
Intervention: PDS with ranibizumab 100 mg/ml with fixed 24‐week refill‐exchanges (PDS Q24W)
Number of subjects: 418

Group type: COMPARATOR
Intervention: Intravitreal ranibizumab 0.5‐mg injections every 4 weeks (monthly ranibizumab)
Number of subjects: 418
Study: 34067795

Group type: EXPERIMENTAL
Intervention: Matcha
Number of subjects: 0

Group type: COMPARATOR
Intervention: Caffeine
Number of subjects: 0
Study: 32381807

Group type: EXPERIMENTAL
Intervention: Combination of 1% curcumin, 1% hyaluronidase, and 0.1% triamcinolone acetonide
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Triamcinolone and hyaluronidase mucoadhesive semisolid gel
Number of subjects: 120

Group type: COMPARATOR
Intervention: 1% curcumin
Number of subjects: 120

Group type: COMPARATOR
Intervention: Triamcinolone-hyaluronidase group
Number of subjects: 120
Study: 36303197

Group type: EXPERIMENTAL
Intervention: Affinos® impregnated with platelet-rich plasma
Number of subjects: 0

Group type: COMPARATOR
Intervention: Affinos® alone (control)
Number of subjects: 0
Study: 33894363

Group type: EXPERIMENTAL
Intervention: Intravenous lidocaine
Number of subjects: 300

Group type: COMPARATOR
Intervention: Intravenous fentanyl
Number of subjects: 300
Study: 33274542

Group type: EXPERIMENTAL
Intervention: Ramucirumab plus Paclitaxel
Number of subjects: 78

Group type: COMPARATOR
Intervention: Control (not specified)
Number of subjects: 78
Study: 32741659

Group type: EXPERIMENTAL
Intervention: Carotid IMT measured after 18 months of intervention in the CIMT trial
Number of subjects: 230

Group type: EXPERIMENTAL
Intervention: Baseline carotid IMT and CV risk factors (age, sex, baseline systolic blood pressure)
Number of subjects: 230

Group type: EXPERIMENTAL
Intervention: Carotid IMT
Number of subjects: 230
Study: 36244200

Group type: EXPERIMENTAL
Intervention: Low frequency rTMS over right DLPFC
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Low frequency rTMS over right OFC
Number of subjects: 60

Group type: COMPARATOR
Intervention: Sham treatment
Number of subjects: 60
Study: 34797287

Group type: EXPERIMENTAL
Intervention: Tai Chi exercise (TC) added to sodium hyaluronate treatment
Number of subjects: 146

Group type: COMPARATOR
Intervention: Sodium hyaluronate (control)
Number of subjects: 146
Study: 32165316

Group type: EXPERIMENTAL
Intervention: Ventolin® Evohaler® with verbal inhaler technique counselling (VC)
Number of subjects: 16

Group type: COMPARATOR
Intervention: Ventolin® Evohaler® connected to Able Spacer® (AS)
Number of subjects: 16
Study: 36175588

Group type: EXPERIMENTAL
Intervention: Sodium valproate (VPA) 60 mg/kg/day for 3 days (D1-D3) followed by oral etoposide 50 mg once daily for two weeks (D4-D17)
Number of subjects: 27

Group type: COMPARATOR
Intervention: Oral etoposide (historical control)
Number of subjects: 27
Study: 34501728

Group type: EXPERIMENTAL
Intervention: Bilateral quadratus lumborum block type I with 24 mL 0.375% ropivacaine
Number of subjects: 60

Group type: COMPARATOR
Intervention: No block (control group)
Number of subjects: 60
Study: 35120491

Group type: COMPARATOR
Intervention: Normotensive controls
Number of subjects: 153

Group type: EXPERIMENTAL
Intervention: Preeclampsia cases
Number of subjects: 153

Group type: EXPERIMENTAL
Intervention: Severe preeclampsia/eclampsia cases
Number of subjects: 153

Group type: EXPERIMENTAL
Intervention: All groups
Number of subjects: 153
Study: 34309117

Group type: COMPARATOR
Intervention: Postoperative radiotherapy (PORT)
Number of subjects: 172

Group type: COMPARATOR
Intervention: Postoperative concurrent chemoradiotherapy (POCRT)
Number of subjects: 172

Group type: EXPERIMENTAL
Intervention: Surgery alone (SA)
Number of subjects: 172
Study: 32337864

Group type: EXPERIMENTAL
Intervention: 3D HD camera
Number of subjects: 30

Group type: COMPARATOR
Intervention: 2D HD camera
Number of subjects: 30
Study: 35491560

Group type: EXPERIMENTAL
Intervention: Warmed intravenous fluids (WIVF)
Number of subjects: 105

Group type: COMPARATOR
Intervention: Routine care using a cotton blanket (Control)
Number of subjects: 105
Study: 33596909

Group type: EXPERIMENTAL
Intervention: C2HEST score
Number of subjects: 2202
Study: 32536320

Group type: EXPERIMENTAL
Intervention: Immersive VR therapeutic intervention
Number of subjects: 90
Study: 35410317

Group type: EXPERIMENTAL
Intervention: Two synbiotics
Number of subjects: 600

Group type: EXPERIMENTAL
Intervention: Probiotic
Number of subjects: 600

Group type: COMPARATOR
Intervention: No supplement (Control)
Number of subjects: 600
Study: 33839450

Group type: EXPERIMENTAL
Intervention: Adjunctive perampanel oral suspension
Number of subjects: 115
Study: 36094318

Group type: EXPERIMENTAL
Intervention: Virtuo
Number of subjects: 9957

Group type: COMPARATOR
Intervention: Bactec FX
Number of subjects: 9957

Group type: EXPERIMENTAL
Intervention: Virtuo (aerobic bottles)
Number of subjects: 9957

Group type: EXPERIMENTAL
Intervention: Virtuo (all bottles)
Number of subjects: 9957
Study: 34398412

Group type: EXPERIMENTAL
Intervention: Zirconia crowns
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Lithium disilicate crowns
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Cast metal crowns
Number of subjects: 60
Study: 32343004

Group type: EXPERIMENTAL
Intervention: Selected adolescents (STEM gifted)
Number of subjects: 2234

Group type: COMPARATOR
Intervention: Unselected adolescents
Number of subjects: 2234
Study: 36002106

Group type: EXPERIMENTAL
Intervention: Single-unit UCB transplantation
Number of subjects: 278

Group type: COMPARATOR
Intervention: Real-world (RW) group with single-unit UCB
Number of subjects: 278

Group type: COMPARATOR
Intervention: Real-world (RW) group
Number of subjects: 278

Group type: COMPARATOR
Intervention: Conditioning regimen (fludarabine 75 mg/m2, total body irradiation 12 Gy, cyclophosphamide 120 mg/kg)
Number of subjects: 278

Group type: EXPERIMENTAL
Intervention: Transplantation strategy failure
Number of subjects: 278
Study: 33503193

Group type: EXPERIMENTAL
Intervention: Low-dose conjugated estrogen (CE) 0.3 mg
Number of subjects: 73

Group type: EXPERIMENTAL
Intervention: Raloxifene 60 mg
Number of subjects: 73

Group type: EXPERIMENTAL
Intervention: Combined therapy (Raloxifene + Low-dose CE)
Number of subjects: 73

Group type: COMPARATOR
Intervention: Control (not specified)
Number of subjects: 73
Study: 32723723

Group type: EXPERIMENTAL
Intervention: ACT intervention via mobile phone messaging robot; twice-daily messages for 2 weeks post-surgery.
Number of subjects: 82

Group type: COMPARATOR
Intervention: Control group; received no messages.
Number of subjects: 82
Study: 35132308

Group type: EXPERIMENTAL
Intervention: Ready-to-use therapeutic foods (RUTF1, RUTF2, RUTF3) formulated from maize grains, pulses (soybeans), and cooking banana fruits.
Number of subjects: 0
Study: 34459077

Group type: EXPERIMENTAL
Intervention: Augmented cognitive behavioral therapy (CBT) adjunctive to treatment as usual (TAU)
Number of subjects: 80

Group type: COMPARATOR
Intervention: Treatment as usual (TAU) alone
Number of subjects: 80